Nano spray-dried pyrazinamide-L-leucine dry powders, physical properties and feasibility used as dry powder aerosols
- PMID: 25331092
- DOI: 10.3109/10837450.2014.971373
Nano spray-dried pyrazinamide-L-leucine dry powders, physical properties and feasibility used as dry powder aerosols
Abstract
Objective: The aim of this study was to investigate the effect of adding L-leucine and using an ethanolic solvent on the physicochemical properties and aerodynamic behavior of nano spray-dried pyrazinamide (PZA)-L-leucine powders.
Materials and methods: A nano spray dryer was employed to prepare PZA-L-leucine powders. The physicochemical properties were evaluated using a scanning electron microscope (SEM), differential scanning calorimetry and X-ray diffraction. The Andersen cascade impactor was used to evaluate the in vitro aerosolization performance of the sprayed powders.
Results and discussion: The incorporation of L-leucine at 10% improved the percentage fine particle fraction (%FPF) in all ethanolic solvent formulations by up to nearly twofold (20.0-23.4%) compared to the normal spray-dried PZA of (8.8-13.0%). Changes in the particle density and morphology were also observed. The dense solid particles of PZA were completely converted to bulk hollow particles with a thin shell by increasing the L-leucine content up to 50%. Higher ethanol concentration resulted in larger dimensions of the hollow particle but did not directly affect the aerosolization performance. The co-spray dried PZA with 20% L-leucine in a 10% ethanol feed solvent gave the best aerosolization performance (FPF = 33.0%).
Conclusions: The co-spray dried PZA with a suitable L-leucine content using a nano spray drying technique could be applied to formulate the PZA DPI.
Keywords: Andersen cascade impactor; dry powder inhaler; lung delivery; nano spray dryer; tuberculosis.
Similar articles
-
L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.Eur J Pharm Biopharm. 2016 May;102:132-41. doi: 10.1016/j.ejpb.2016.02.010. Epub 2016 Mar 9. Eur J Pharm Biopharm. 2016. PMID: 26970252
-
Phospholipid-based pyrazinamide spray-dried inhalable powders for treating tuberculosis.Int J Pharm. 2016 Jun 15;506(1-2):174-83. doi: 10.1016/j.ijpharm.2016.04.038. Epub 2016 Apr 28. Int J Pharm. 2016. PMID: 27091294
-
Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate.Int J Pharm. 2016 Mar 30;501(1-2):124-38. doi: 10.1016/j.ijpharm.2016.01.066. Epub 2016 Feb 1. Int J Pharm. 2016. PMID: 26836711
-
Leucine as an excipient in spray dried powder for inhalation.Drug Discov Today. 2021 Oct;26(10):2384-2396. doi: 10.1016/j.drudis.2021.04.009. Epub 2021 Apr 17. Drug Discov Today. 2021. PMID: 33872799 Review.
-
Spray-Dried PulmoSphere™ Formulations for Inhalation Comprising Crystalline Drug Particles.AAPS PharmSciTech. 2019 Feb 7;20(3):103. doi: 10.1208/s12249-018-1280-0. AAPS PharmSciTech. 2019. PMID: 30734187 Review.
Cited by
-
Rifampicin-Carbohydrate Spray-Dried Nanocomposite: A Futuristic Multiparticulate Platform For Pulmonary Delivery.Int J Nanomedicine. 2019 Nov 22;14:9089-9112. doi: 10.2147/IJN.S211182. eCollection 2019. Int J Nanomedicine. 2019. PMID: 31819421 Free PMC article.
-
Novel Approaches for the Treatment of Pulmonary Tuberculosis.Pharmaceutics. 2020 Dec 10;12(12):1196. doi: 10.3390/pharmaceutics12121196. Pharmaceutics. 2020. PMID: 33321797 Free PMC article. Review.
-
In vivo pharmacokinetic and pharmacodynamic study of co-spray-dried inhalable pirfenidone microparticles in rats.Drug Deliv. 2022 Dec;29(1):3384-3396. doi: 10.1080/10717544.2022.2149899. Drug Deliv. 2022. PMID: 36415157 Free PMC article.
-
Development and Characterization of a Dry Powder Formulation for Anti-Tuberculosis Drug Spectinamide 1599.Pharm Res. 2019 Jul 18;36(9):136. doi: 10.1007/s11095-019-2666-8. Pharm Res. 2019. PMID: 31321552 Free PMC article.
-
Development and Pharmacokinetics of a Novel Acetylsalicylic Acid Dry Powder for Pulmonary Administration.Pharmaceutics. 2022 Dec 15;14(12):2819. doi: 10.3390/pharmaceutics14122819. Pharmaceutics. 2022. PMID: 36559312 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources